We examined bovine aortic endothelial cells (BAECs) for the functional expression of P2X receptors, the ATP-gated cation channels. We identified the P2X subtypes present in the BAECs using RT-PCR. mRNA was present for only three of the seven family members, P2X4, P2X5 and P2X7. We then characterized agonist-activated currents in whole cell and outside-out patch recording using 2-methyl-thio-ATP (MeSATP) as a P2X4 and P2X5 receptor agonist and 2'3'-O-(4-benzoylbenzoyl)ATP (BzATP), as a P2X7 receptor agonist. MeSATP (10-20 mM)
INTRODUCTION
Activation of purinergic receptors on vascular endothelium triggers a wide spectrum of physiological actions including an increase in cytosolic calcium that may be followed by secretion of nitric oxide, ATP, prostacyclin, endothelin or other substances. Furthermore, lengthy exposure to ATP is reported to produce apoptotic or necrotic cell death (6, 20, 30) . Many of the actions of ATP have been attributed to members of the P2Y family of metabotropic purinoreceptors that have been well documented in endothelium (5, 14, 36) .
Only recently has the presence of members of the P2X family of ionotropic purinergic receptors been reported in endothelium (10, 11, 13, 21, 41, 42) and there is still little functional characterization of the receptors in these cells. P2X receptors are calcium permeable, cation-selective channels with diverse pharmacological and desensitization phenotypes that are expected to affect their role in cell signaling (1, 2, 16, 31, 32, 38) . In addition, several members of the P2X family, most notably P2X7 but also P2X2-4, have the interesting capacity to initiate a second state of high conductance (pores) when activated by agonist (15, 25, 26, 37) . In the case of P2X7, this may lead to sustained calcium influx and cell death.
In previous studies we characterized the ion channels of bovine aortic endothelial cells (BAECs) that open in response to ATP-induced depletion of calcium stores via G-protein coupled P2Y receptor activation (35). In the course of those studies it was apparent that ATP also activated a second calcium permeable ion channel with different characteristics than the store-operated channel. With the P2X receptor/channels as likely candidates, the present study had the following two objectives: to obtain electrophysiological characterization of the structurally identified receptors in bovine aortic 2 endothelial cells and to establish whether, in addition to activation of small cation channels, pore formation occurred in these cells in response to agonist.
We show that BAECs contain mRNA for P2X4, P2X5 and P2X7 and not for the other P2X receptors.
Channels with the pharmacological and electrophysiological properties of P2X7 and P2X4 are both functionally present in the surface membrane. Channels with properties particular to P2X5 were not seen, presenting the possibility that P2X5 exists in combination with P2X4 as a heteromultimer that expressing the properties of P2X4. Pore formation was not present under a variety of conditions that elicit permeability to large molecules such as NMDG and YO-PRO in other cell types in response to ATP.
METHODS

Tissue.
Bovine aortic endothelial cells were obtained from Cell Systems Corporation (Kirkland, WA). They were grown in Dulbecco's modified Eagle's Medium (GibcoBRL) supplemented with 10% fetal calf serum, penicillin (100 units/ml) and streptomycin (100 mg/ml). For mRNA preparation, adult rats placed under halothane anesthesia were decapitated and the nodose ganglia and brains were for 5 min and then reverse-transcribed into first-strand cDNA using a mixture of random hexameric, unlabelled deoxynucleotides and MuLV Reverse Transcriptase (First-Strand cDNA Synthesis Kit, Perkin-Elmer) at 42°C for 1 hr. The first-strand cDNA products were used directly as templates for PCR amplification. PCR was performed with the Advantage PCR System (Clontech) as follows.
Each PCR vessel contained 5 pmol each of the sense and antisense primers, 0.2 mM deoxynucleotides, and one unit of AdvanTaq in a final volume of 25 ml. The amplifications were performed using the following cycling program: one cycle (2 min at 95°C); 35 cycles (15 sec at 94°C, 15 sec at 55°C, 1 min at 68°C); one cycle (10 min at 72°C). PCR products of P2X1-7
purinoreceptors from endothelial cells, nodose ganglia (P2X1-6) and brain (P2X7) were resolved by electrophoresis on 1.2% agarose gels, and transferred to BrightStar-Plus nylon membranes (Ambion)
as recommended by the manufacturer. Following transfer, the membranes were baked at 80°C in a vacuum oven. Subunits specific PCR products were identified by hybridization to radiolabeled internal oligonucleotides specific for each one of the P2X receptors. The internal oligonucleotides were as follows: P2X1 (5'-TCA CCT CTT CAA GGT GTT TGG GAT TC-3'); P2X2 (5'-AGA GCT CCA TCA TCA CCA AGG TCA AGG GGA TCA C-3'); P2X3 (5'-ACT ACA GCT CTG TTC TCC GGA CCT GTG-3'); P2X4 (5'-GGC ATC CGC TTT GAC ATC ATC GTG TTT G-3');
P2X5 (5'-CTG ATG AAA GCC TAC GGG ATC CGC TTT G-3'); P2X6 (5'-GTG TTC CGC ATT GGG GAC CTC GTG G-3'); P2X7 (5'-TAA AAA GGG ATG GTT GGG CCC GCG GAG CAA AG-3'). Radiolabeling was accomplished with T4 Polynucleotide Kinase (Promega) in the presence of [g-32 P] ATP (Amersham). After the blots were prehybridized in Ultrasensitive Hybridization Solution (ULTRAhyb, Ambion) at 42 °C for 1 hr, [ 32 P]-labeled probe (at 10 6 cpm/ml) was added and hybridized at 42 °C for up to 16 hrs. After hybridization, the blots were washed first with 2x SSC/0.1% SDS at room temperature followed by a more stringent wash of 0.1x SSC/0.1% SDS at 44
°C. Blots were exposed to BioMaxMS film (Kodak) at -80 °C with an intensifying screen.
Western blot. Samples of BAECs, rat brain and nodose ganglia were homogenized in ten volumes of lysis buffer (1% Triton-X 100, 150 mM NaCl, 50 mM Tris and 1 mM EDTA at pH 7.5) containing freshly added protease inhibitor cocktail (Complete, Roche Molecular Biologicals) with 50 mM sodium fluoride and 0.2 mM sodium vanadate. The homogenate was incubated on ice for 1 h. Debris and insoluble material were pelleted by centrifugation at 3,000 x g 10 min at room temperature. Concentration of protein in the supernatant was quantified using the BCA method (Pierce). For the Western blot experiments with the P2X7 receptor, a gradient fractionation from
BAECs was made and a sample from the membrane protein fraction (7.5 µg) used for immunoblots.
To prepare membranes from cultured cells, monolayers in 100 mm tissue culture dishes were washed twice with cold PBS, collected in 1 ml cold PBS by scraping, and pelleted in microfuge tubes at 1000 x g for 5 min. Cells were lysed by resuspension in a hypotonic lysis buffer (250 ml/cells from one 100 mm dish) consisting of (in mM) 10 HEPES pH 7.9, 10 KCl, 1.5 MgCl 2 plus a protease inhibitor cocktail (Complete, Roche Mol. Biol.), NaF (50 mM), and Na 3 VO 4 (1 mM).
After a 15 min incubation on ice, cells were passed 10 times through a 26 gauge needle. Nuclei and unbroken cells were removed by spinning at 1000 x g for 10 min at 4°C. The supernatant was spun at 10,000 x g (10 min at 4°C) to remove mitochondria after which membranes were pelleted by spinning at 50,000 x g for one hr. The supernatant was saved as the cytosolic fraction. The membrane pellet was washed once by resuspension in lysis buffer and recentrifuged to remove cytosolic contaminants. The final membrane pellet was solubilized in an isotonic lysis buffer containing 1% TX-100. After a 30 min incubation on ice, insoluble debris was removed by centrifugation at 20,000 x g for 10 min. Lysate from rat brain (1µg) was used as a positive control.
For P2X4, a sample from rat nodose ganglia lysate was used as a positive control and run in parallel with total protein from BAECs (10 µg per line). In both cases the samples of protein were separated on 7.5 % polyacrilamide SDS gels and transferred to PVDF membranes. The PVDF membranes were blocked with 5% non-fat dry milk in PBS-0. Images were obtained with a Spot 2.1 digital camera (Diagnostic Instruments) or examined using confocal microscopy (Leica).
Electrophysiology. Whole-cell and outside-out patch configurations were used. The currentvoltage relationship was obtained using either a voltage ramp (-120 mV to +60 mV) or a series of step depolarizations (-100 to +40 mV) from a holding potential of -60 mV. A BAECs monolayer was mechanically dissociated to single cells and re-plated. Single cells were studied after allowing 10 min for reattachment. Whole cell and outside-out recordings were made using an Axopatch-1C amplifier (Axon instruments). Patch pipettes (3-7 MW) were made from borosilicate glass 7052 (Garner Glass). Data was digitized at 50-100 ms/point and the results were analyzed using pClamp analysis package (Axon Instruments purchased from RBI. Agonists and antagonists were prepared fresh, unless previously prepared as stock solutions and frozen in aliquots. They were defrosted and diluted in the buffer just before use.
The agonists and antagonists were applied from a large multibore pipette placed close to the cell just prior to application. At the end of the incubation times, the monolayer was washed with the buffer and the field of cells examined for YO-PRO fluorescence (excitation 612 nm/emission 631 nm). mM) and voltage ramps were repeated. In a simultaneous set of experiments we used ATP in a concentration range (10-100 mM) that would be expected to activate P2X4 and P2X5 but not P2X7.
YO-PRO
RESULTS
Detection of P2X receptors subunits in
These concentrations elicited current with pharmacology and kinetics equivalent to that of MeSATP.
In the presence of either MeSATP or ATP, an inward current developed (Fig 3A,B) . . Reactive blue at 60mM was also ineffective in blocking the agonist current ( Figure 4C ).
An identical ramp protocol was used to activate channels in outside-out patches. Channel activity was induced when the patch was superfused with MeSATP or ATP in 10 of 19 outside-out patches.
Most active patches (8/10) contained more than one channel. Examples of responses to ATP and MeSATP during the ramp and in the 2 sec interval at -60 mV between ramps are shown in figures 5A and 5C, respectively, where data was obtained from patches that appeared to contain only one active channel (no overlapping events in spite of long openings). In the continued presence of the agonist the activity seldom lasted more than 15-30 sec although, as in the whole cell studies, the single channel activity could be reactivated following an interval of 3-4 min. Also, as in whole cell studies, suramin was ineffective in blocking channel activity in the outside-out patches.
Single channel amplitudes from 8 patches (4 in MeSATP and 4 in ATP), measured during the ramps and at the -60mV holding potential, were combined for display against membrane potential in figure   5B . A linear regression through the data points gave a conductance of 36±3 pS and a reversal P2X7. In contrast to the MeSATP-activated current described above, BzATP-activated currents in
BAECs decayed toward a sustained value in the continued presence of the agonist (Fig 6A) . The reversal potential remained near zero mV whether the pipette contained Cl -or MeSO4 -(n=3), thus eliminating chloride as the current carrying species. Furthermore, this current was not carried by the large cations that are characteristic of the pore formation described for P2X7 in other cell types. In the continued presence of BzATP with the membrane potential held at -60 mV, NMDG + , substituted for Na + in the bath, eliminated the BzATP-activated inward current (Fig. 6) . During a second application of the NMDG bathing solution, the holding potential was briefly switched from -60 mV through zero mV to +60 mV. The extrapolated zero current potential was shifted toward negative values as shown in figure 6B . These currents were obtained in low-divalent bath solution (0. BzATP (100mM) the low divalent bathing solution. We were unable to elicit a current that was carried by NMDG. As a control, BzATP-activated an NMDG-permeable current in a P2X7 expressing cell line under these conditions (not shown). To further characterize the P2X7 resopnse we examined the effects of the two antagonists, suramin and reactive blue. High concentrations of suramin (300 mM) produced a reversible 50% block of the current at the most negative potentials while 100 mM had only a small (7 and 10%, n=2) effect (Fig 6C) . Reactive blue (60 mM) completely blocked the BzATP activated response (n=2, Fig 6D) .
In an outside-out patch BzATP (100 mM) elicited single channel activity as shown at holding potentials of -80 and -100 mV in a normal divalent solution (Fig. 7 ). An example of the single channel response obtained in the presence of BzATP is shown in figure 6B at a series of different holding potentials. The conductance calculated in this patch was 9.8 pS (Fig 7C) . Current-voltage relationships from measurements from six patches gave a conductance of 8.5 ± 1.1 pS. These patches all contained several active channels.
The electrophysiological experiments produced no evidence for BzATP-induced pore formation. To rule out the possibility that our recordings disturbed an intracellular component that was necessary for pore formation we used the second approach that has been favored for examination of pore formation, the uptake of the large cation, YO-PRO. After entering the cell this molecule fluoresces upon binding to RNA and DNA and thus serves as an indicator of large pore formation.
YO-PRO uptake.
We examined the cells for permeability to YO-PRO in the presence of BzATP, ATP or MeSATP. A typical YO-PRO uptake experiment is shown in figure 8 . A monolayer of BAECs was incubated in the extracellular solution containing 3 mM YO-PRO. After 5 min of incubation the solution was changed to one containing 3 mM YO-PRO, plus 100 mM BzATP and maintained for 30 min. YO-PRO did not appear as intranuclear fluorescence although there was a weak increase in cytosolic fluorescence after the 30 min time period (Fig. 8B ). This may suggest the presence of a few large channels passing the YO-PRO that binds to cytoplasmic nucleic acids. As a control, permeablization with Triton X-100 produced strong nuclear labeling. Similar experiments (where n ³ 3 for each condition) were performed in normal and low divalents, at both room temperature (19-22°C) and at 37°C, but YO-PRO labeling of the nuclei was not observed.
Immunocytochemical localization provides further support for functional presence of P2X4
and P2X7 receptors. We next investigated the distribution of P2X4 and P2X7 immunoreactivity at the cellular level with two commercially available antibodies (Fig. 9) . Staining with anti-P2X4
showed a localization of this subunit in perinuclear regions as well as diffuse distribution in the cytoplasm up to the cell borders. Anti-P2X7 staining also localized to the perinuclear area, the cytoplasm and, in addition, was also very clearly delineated at the cell borders. A Z-section confocal line scan shows P2X4 and P2X7 bordering the cell surface in what appear to be patches of immunoreactive material.
DISCUSSION
This is the first electrophysiological evaluation of P2X receptors in endothelial cells. One aspect of the present study supports a recent report that demonstrated that P2X4 message is abundant in endothelium and that the P2X4 subunit contributes to ATP-activated calcium influx as reported using Indo-1 (41). These authors also report the presence of mRNA for P2X7 although the protein was not functionally characterized. In that study human aortic endothelial cells produced only a very weak signal from P2X5 while ours was stronger in BAECs, although weaker than the signals for P2X4 and P2X7. The complement of P2X receptor/channels in endothelial cells is likely to depend upon the anatomical location and species since P2X2 receptors have been localized to endothelial cells of several major arteries (13) , to cerebral vessels (21) and P2X3 has been observed in endothelial cells in thymus gland (11) . Glass and Burnstock (10) also localized P2X3 as well as P2X4 and P2X7 to endothelial cells in rat thyroid gland.
Since at least five different P2 receptors (P2X4, P2X5, P2X7, P2Y1, P2Y2) have been reported in the BAECs, all of which are able to increase calcium influx, it is logical to ask whether they play distinct roles in regulating intracellular calcium and cellular function. This is important because calcium has been implicated not only in modulating secretion but also in regulating gene expression.
The interesting problem is whether distinct receptors are tied to specific responses through their surface localization. Calcium influx through a particular receptor might activate calcium-sensitive pathways that are co-localized at those sites. This could lead to secretion of a specific substance or expression of particular genes. Knowledge of receptor distribution, kinetics and pharmacology of specific receptors may contribute to unraveling the contributions of specific subtypes.
P2X4 and P2X5 channels
The A characteristic of heterologously expressed P2X4 channels differing from the present study is the reported 9 pS single channel conductance (7, 23) , smaller than the predominant conductance of 36 pS we observed. No reports of P2X5 single channel conductances are yet available for comparison.
However, a discrepancy in conductance between expressed and native P2X channels has been reported for other P2X receptors and suggests that other as yet unknown factors, such as auxiliary subunits, may determine the amplitude of the channel activity (39).
The P2X channels differ from the P2Y receptor-activated store-operated channels (SOC)
The P2Y receptors in endothelial cells (P2Y1, P2Y2, P2Y11) are G-protein linked and activate the phosphoinositol system leading to store-operated calcium influx following IP 3 -induced release of calcium from intracellular stores and, in the case of P2Y11, also linked to cAMP/PKA pathway. The SOC differs from that observed in the present studies. It exhibits anomalous mole fraction behavior and a reversal potential that reflects the high calcium permeability. Its single channel conductance is about 2 pS in 2 mM extracellular calcium (35). Furthermore, the P2Y receptors are reported to be blocked by suramin, in contrast to the MeSATP-activated channel in the present studies.
P2X7 Channels
The P2X7 receptor is, uniquely among the P2X4, P2X5 and P2X7 receptors, insensitive to low concentrations of ATP, £100mM, but activated by low concentrations of BzATP (10 mM). The response of the endothelial cells to BzATP (10-100 mM) is clearly distinct from that of MeSATP or ATP (10-100 mM). The BzATP activated inward current response shows only a slow decay over many minutes in the continued presence of agonist. The single channel amplitude in the present study was 9 pS, consistent with measurements of 10 pS in B-lymphocytes where P2X7 is a prevalent channel (22). The BzATP-activated response is 50% blocked by 300 mM suramin which did not block the MeSATP response, consistent with the reports of the P2X7 receptor. Finally, the BzATPactivated current was completely blocked by 60 mM reactive blue while the MeSATP response was not blocked. These data support the contention that the BzATP-activated response is via the P2X7 receptor.
A BzATP-activated channel that is permeable to small cations, appears to give rise to formation of large channels or pores that are permeable to NMDG + , ethidium bromide and YO-PRO as extensively documented in mast cells, macrophages, microglia and lymphocytes. Pore formation has recently also been reported for P2X2, P2X3 and P2X4, although the response is less dramatic (15, 37) . Pore formation is favored by reducing extracellular sodium, raising temperature, reducing extracellular Mg 2+ and Ca 2+ or long duration application of agonist (15, 26) . In spite of the fact that we used all these maneuvers, we were unable to induce the formation of large pores as measured by NMDG + permeability or by YO-PRO uptake. In fact, we only infrequently observed the rapid opening and closing of a large non-selective channel in response to ATP or MeSATP that might be attributed to a "pore". Pore formation has been postulated to arise from the expansion of the smaller P2X7 channel or, alternatively, from the addition of subunits to the channel. In BAECs we conclude that the link between ATP-activation of the small channel and formation of the "pore" is either not present or functions under, as yet, unidentified conditions. Lack of pore formation is not without precedent. In oocytes, expression of P2X7 did not give rise to permeability to large molecules (28).
P2X7 receptors in Muller glial cells from the human retina are also do not form pores (27). A recent report proposes that the pore is, in fact, a separate entity that is activated subsequent to agonist stimulation by an unknown mechanism (29).
In summary, the two distinct currents that may be attributed to P2X7 and to P2X4 (perhaps in association with P2X5) exhibit different rates and amounts of desensitization in response to application of agonist. Thus, calcium influx through P2X4 would be transient and is in agreement with the recovery of intracellular calcium in endothelial cells in the continued presence of ATP (41).
Calcium influx through P2X7 in endothelium would be expected to be sustained over many minutes.
These, and the previously described differences in sensitivity to ATP (25), would seem to assign different roles to these two purinergic receptors in endothelium. 
